Tyrosine Hydroxylase- and Dopamine Transporter-Immunoreactive Axons in the Primate Cerebellum
暂无分享,去创建一个
[1] S. Haber,et al. Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.
[2] A. Rivera,et al. Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.
[3] K. D. Tran,et al. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. , 1998, The American journal of psychiatry.
[4] Allan I. Levey,et al. Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.
[5] J. Schmahmann,et al. The cerebellar cognitive affective syndrome. , 1998, Brain : a journal of neurology.
[6] M. Kuhar. Recent biochemical studies of the dopamine transporter--a CNS drug target. , 1998, Life sciences.
[7] C Kennard,et al. Oculomotor abnormalities in schizophrenia , 1998, Neurology.
[8] S. Sesack,et al. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.
[9] P. Goldman-Rakic. The cortical dopamine system: role in memory and cognition. , 1998, Advances in pharmacology.
[10] J N Giedd,et al. Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. , 1997, The American journal of psychiatry.
[11] G McKay,et al. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. , 1997, The American journal of psychiatry.
[12] M. Caron,et al. The dopamine transporter: A crucial component regulating dopamine transmission , 1997, Movement disorders : official journal of the Movement Disorder Society.
[13] A Carlsson,et al. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. , 1997, Life sciences.
[14] D. Mash,et al. Immunochemical analysis of dopamine transporter protein in Parkinson's disease , 1997, Annals of neurology.
[15] Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] S. Sesack,et al. Chapter VI Dopamine systems in the primate brain , 1997 .
[17] J. B. Levitt,et al. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex , 1996, The Journal of comparative neurology.
[18] Christer Halldin,et al. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients , 1996, Psychiatry Research: Neuroimaging.
[19] N C Andreasen,et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] Adriaan A. Lammertsma,et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease , 1996, Journal of Neuroscience Methods.
[21] N. Volkow,et al. MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. , 1996, Journal of computer assisted tomography.
[22] G. Uhl,et al. Dopamine transporter immunoreactivity in rat brain , 1995, The Journal of comparative neurology.
[23] F. Moeller,et al. Cerebellar blood flow in schizophrenic patients and normal control subjects , 1995, Psychiatry Research: Neuroimaging.
[24] M. Martres,et al. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.
[25] S. Hersch,et al. The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[26] P. Strick,et al. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. , 1994, Science.
[27] J. Haycock,et al. Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain , 1994, Brain Research.
[28] M. Egan,et al. Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study , 1994, Brain Research.
[29] P. Strick,et al. Activation of a cerebellar output nucleus during cognitive processing. , 1994, Science.
[30] N. Mendell,et al. Eye tracking and schizophrenia: a selective review. , 1994, Schizophrenia bulletin.
[31] M. Akil,et al. The dopaminergic innervation of monkey entorhinal cortex. , 1993, Cerebral cortex.
[32] A. Fuchs,et al. Role of the caudal fastigial nucleus in saccade generation. I. Neuronal discharge pattern. , 1993, Journal of neurophysiology.
[33] J. Haycock,et al. Four isoforms of tyrosine hydroxylase are expressed in human brain , 1993, Neuroscience.
[34] E Ryding,et al. Motor imagery activates the cerebellum regionally. A SPECT rCBF study with 99mTc-HMPAO. , 1993, Brain research. Cognitive brain research.
[35] S E Petersen,et al. The processing of single words studied with positron emission tomography. , 1993, Annual review of neuroscience.
[36] N. Mizuno,et al. Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei , 1992, Neuroscience.
[37] N. Volkow,et al. Low cerebellar metabolism in medicated patients with chronic schizophrenia. , 1992, The American journal of psychiatry.
[38] A. Grace. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.
[39] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[40] J. Schmahmann. An emerging concept. The cerebellar contribution to higher function. , 1991, Archives of neurology.
[41] N. Panagopoulos,et al. Dopaminergic innervation and binding in the rat cerebellum , 1991, Neuroscience Letters.
[42] M. Wolf,et al. Effect of Aging on Tyrosine Hydroxylase Protein Content and the Relative Number of Dopamine Nerve Terminals in Human Caudate , 1991, Journal of neurochemistry.
[43] P. Goldman-Rakic,et al. D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.
[44] B. Berger,et al. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.
[45] Kisou Kubota,et al. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex , 1988, Neuroscience Research.
[46] Masao Ito. The Cerebellum And Neural Control , 1984 .
[47] T. Vilis,et al. Characteristics of saccadic dysmetria in monkeys during reversible lesions of medial cerebellar nuclei. , 1981, Journal of neurophysiology.
[48] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[49] J. Kleinman,et al. Cerebellar pathology in schizophrenia: a controlled postmortem study. , 1980, The American journal of psychiatry.
[50] H. E. Rosvold,et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.
[51] A. Björklund,et al. Organization of Catecholamine Neurons in the Rat Central Nervous System , 1978 .
[52] Dominic W. Hughes,et al. Eye-Tracking Patterns in Schizophrenia , 1973, Science.
[53] S. Snyder,et al. Catecholamines in the brain as mediators of amphetamine psychosis. , 1972, Archives of general psychiatry.
[54] M. Carpenter,et al. Cerebellum of the rhesus monkey : atlas of lobules, laminae, and folia, in sections , 1971 .
[55] Á.,et al. Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex , 2022 .